Green tomato extract attenuates high-fat-diet-induced obesity through activation of the AMPK pathway in C57BL/6 mice

Journal of Nutritional Biochemistry

Volumn 24, Issue 1, 2013, Pages 335-342

  Choi, Kyeong Mi ^a   Lee, Youn Sun ^a   Shin, Dong Mi ^a   Lee, Seunghyun ^a   Yoo, Kwang Sik ^a   Lee, Mi Kyeong ^a   Lee, Jae Hak ^b   Kim, Sun Yeou ^c   Lee, Yong Moon ^a   Hong, Jin Tae ^a   Yun, Yeo Pyo ^a   Yoo, Hwan Soo ^a  

^a Chungbuk National University   (South Korea)

^b Korea Plant Resource Institute   (South Korea)

^c Gachon University College of Medicine   (South Korea)

Author keywords

AMPK; C57BL 6 mice; Obesity; Tomato

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADENYLATE KINASE; ANTIOBESITY AGENT; CCAAT ENHANCER BINDING PROTEIN; CHOLESTEROL; GREEN TOMATO EXTRACT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PERILIPIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLANT EXTRACT; RED TOMATO EXTRACT; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EPIDIDYMIS FAT; FOOD INTAKE; GREEN TOMATO; LIPID DIET; LIVER; MALE; MOUSE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; RED TOMATO; TOMATO; WEIGHT REDUCTION;

3T3-L1 CELLS; ACETYL-COA CARBOXYLASE; ADIPOSE TISSUE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANTI-OBESITY AGENTS; BODY WEIGHT; CARRIER PROTEINS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL DIFFERENTIATION; CHOLESTEROL; DIET, HIGH-FAT; EATING; LIPIDS; LIVER; LYCOPERSICON ESCULENTUM; MALE; MICE; MICE, INBRED C57BL; OBESITY; ORGAN SIZE; PHOSPHOPROTEINS; PHOSPHORYLATION; PLANT EXTRACTS; PPAR GAMMA; TOMATINE;

LYCOPERSICON ESCULENTUM; MUS;

EID: 84870411087     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2012.06.018     Document Type: Article

References (34)

1. Roberts A.W., Clark A.L., Witte K.K. Review article: left ventricular dysfunction and heart failure in metabolic syndrome and diabetes without overt coronary artery disease - do we need to screen our patients?. Diab Vasc Dis Res 2009, 6:153-163.
2. Barr E.L., Cameron A.J., Balkau B., Zimmet P.Z., Welborn T.A., Tonkin A.M., et al. HOMA insulin sensitivity index and the risk of all-cause mortality and cardiovascular disease events in the general population: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab) study. Diabetologia 2010, 53:79-88.
3. Hastie C.E., Padmanabhan S., Slack R., Pell A.C., Oldroyd K.G., Flapan A.D., et al. Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary intervention. Eur Heart J 2010, 31:222-226.
4. Spiegelman B.M., Flier J.S. Obesity and the regulation of energy balance. Cell 2001, 104:531-543.
5. Kahn B.B., Alquier T., Carling D., Hardie D.G. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 2005, 1:15-25.
6. Hardie D.G., Scott J.W., Pan D.A., Hudson E.R. Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett 2003, 546:113-120.
7. Carling D., Zammit V.A., Hardie D.G. A common bicyclic protein kinase cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesis. FEBS Lett 1987, 223:217-222.
8. Hardie D.G. Regulation of fatty acid and cholesterol metabolism by the AMP-activated protein kinase. Biochim Biophys Acta 1992, 1123:231-238.
9. Hardie D.G., Corton J., Ching Y.P., Davies S.P., Hawley S. Regulation of lipid metabolism by the AMP-activated protein kinase. Biochem Soc Trans 1997, 25:1229-1231.
10. Rosen E.D., Spiegelman B.M. PPARgamma : a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 2001, 276:37731-37734.
11. Kao Y.H., Hiipakka R.A., Liao S. Modulation of obesity by a green tea catechin. Am J Clin Nutr 2000, 72:1232-1234.
12. Matsuda H., Chisaka T., Kubomura Y., Yamahara J., Sawada T., Fujimura H., et al. Effects of crude drugs on experimental hypercholesterolemia. I. Tea and its active principles. J Ethnopharmacol 1986, 17:213-224.
13. Klaus S., Pultz S., Thone-Reineke C., Wolfram S. Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation. Int J Obes (Lond) 2005, 29:615-623.
14. Wolfram S., Raederstorff D., Wang Y., Teixeira S.R., Elste V., Weber P. TEAVIGO (epigallocatechin gallate) supplementation prevents obesity in rodents by reducing adipose tissue mass. Ann Nutr Metab 2005, 49:54-63.
15. Hsu Y.M., Lai C.H., Chang C.Y., Fan C.T., Chen C.T., Wu C.H. Characterizing the lipid-lowering effects and antioxidant mechanisms of tomato paste. Biosci Biotechnol Biochem 2008, 72:677-685.
16. Friedman M., Fitch T.E., Yokoyama W.E. Lowering of plasma LDL cholesterol in hamsters by the tomato glycoalkaloid tomatine. Food Chem Toxicol 2000, 38:549-553.
17. Beecher G.R. Nutrient content of tomatoes and tomato products. Proc Soc Exp Biol Med 1998, 218:98-100.
18. Leonardi C., Ambrosino P., Esposito F., Fogliano V. Antioxidative activity and carotenoid and tomatine contents in different typologies of fresh consumption tomatoes. J Agric Food Chem 2000, 48:4723-4727.
19. Takagi K., Toyoda M., Shimizu M., Satoh T., Saito Y. Determination of tomatine in foods by liquid chromatography after derivatization. J Chromatogr A 1994, 659:127-131.
20. Friedman M. Tomato glycoalkaloids: role in the plant and in the diet. J Agric Food Chem 2002, 50:5751-5780.
21. Choi S.H., Lee S.H., Kim H.J., Lee I.S., Kozukue N., Levin C.E., et al. Changes in free amino acid, phenolic, chlorophyll, carotenoid, and glycoalkaloid contents in tomatoes during 11 stages of growth and inhibition of cervical and lung human cancer cells by green tomato extracts. J Agric Food Chem 2010, 58:7547-7556.
22. Freedman B.D., Lee E.J., Park Y., Jameson J.L. A dominant negative peroxisome proliferator-activated receptor-gamma knock-in mouse exhibits features of the metabolic syndrome. J Biol Chem 2005, 280:17118-17125.
23. Choi K.M., Lee Y.S., Choi M.H., Sin D.M., Lee S., Ji S.Y., et al. Inverse relationship between adipocyte differentiation and ceramide level in 3T3-L1 cells. Biol Pharm Bull 2011, 34:912-916.
24. Pandey D.K., Shekelle R., Selwyn B.J., Tangney C., Stamler J. Dietary vitamin C and beta-carotene and risk of death in middle-aged men. The Western Electric Study. Am J Epidemiol 1995, 142:1269-1278.
25. Lazarus S.A., Bowen K., Garg M.L. Tomato juice and platelet aggregation in type 2 diabetes. JAMA 2004, 292:805-806.
26. Friedman M., Fitch T.E., Levin C.E., Yokoyama W.H. Feeding tomatoes to hamsters reduces their plasma low-density lipoprotein cholesterol and triglycerides. J Food Sci 2000, 65:897-900.
27. Cayen M.N. Effect of dietary tomatine on cholesterol metabolism in the rat. J Lipid Res 1971, 12:482-490.
28. Yoshinari O., Sato H., Igarashi K. Anti-diabetic effects of pumpkin and its components, trigonelline and nicotinic acid, on Goto-Kakizaki rats. Biosci Biotechnol Biochem 2009, 73:1033-1041.
29. Wu C.H., Yang M.Y., Chan K.C., Chung P.J., Ou T.T., Wang C.J. Improvement in high-fat diet-induced obesity and body fat accumulation by a Nelumbo nucifera leaf flavonoid-rich extract in mice. J Agric Food Chem 2010, 58:7075-7081.
30. Ejaz A., Wu D., Kwan P., Meydani M. Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice. J Nutr 2009, 139:919-925.
31. Seo J.B., Choe S.S., Jeong H.W., Park S.W., Shin H.J., Choi S.M., et al. Anti-obesity effects of Lysimachia foenum-graecum characterized by decreased adipogenesis and regulated lipid metabolism. Exp Mol Med 2011, 43:205-215.
32. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001, 108:1167-1174.
33. Gregoire F.M., Smas C.M., Sul H.S. Understanding adipocyte differentiation. Physiol Rev 1998, 78:783-809.
34. Arimura N., Horiba T., Imagawa M., Shimizu M., Sato R. The peroxisome proliferator-activated receptor gamma regulates expression of the perilipin gene in adipocytes. J Biol Chem 2004, 279:10070-10076.